Massachusetts General Hospital First to Enroll Adults with Down Syndrome in New Nation-Wide Research Study Supported by LuMind IDSC Foundation
The Massachusetts General Hospital (MGH) Down Syndrome Program was the first approved research site in the first clinical trial in the Down Syndrome – Clinical Trials Network (DS-CTN) supported by LuMind IDSC Foundation. MGH is enrolling adults with Down Syndrome over the age of 25 in the Longitudinal Investigation for[…]
Read more